These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38024578)
21. Prevention of shingles: safety and efficacy of live zoster vaccine. Quan D; Cohrs RJ; Mahalingam R; Gilden DH Ther Clin Risk Manag; 2007 Aug; 3(4):633-9. PubMed ID: 18472986 [TBL] [Abstract][Full Text] [Related]
22. Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain? Harbecke R; Jensen NJ; Depledge DP; Johnson GR; Ashbaugh ME; Schmid DS; Breuer J; Levin MJ; Oxman MN Vaccine; 2020 Jan; 38(2):150-157. PubMed ID: 31679866 [TBL] [Abstract][Full Text] [Related]
23. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372 [TBL] [Abstract][Full Text] [Related]
24. Current scenario and future applicability of antivirals against herpes zoster. Kim SH Korean J Pain; 2023 Jan; 36(1):4-10. PubMed ID: 36573010 [TBL] [Abstract][Full Text] [Related]
25. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo. Zerboni L; Arvin A PLoS Pathog; 2015 Jun; 11(6):e1004989. PubMed ID: 26090802 [TBL] [Abstract][Full Text] [Related]
26. Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature. Wang L; Verschuuren EAM; van Leer-Buter CC; Bakker SJL; de Joode AAE; Westra J; Bos NA Front Immunol; 2018; 9():1632. PubMed ID: 30079064 [TBL] [Abstract][Full Text] [Related]
27. A Bilateral Lumbar Multidermatomal Herpes Zoster in an Elderly Woman with Chronic Kidney Disease. Puntillo F; Giglio M; Preziosa A; Mele R; Brienza N Pain Ther; 2020 Dec; 9(2):793-795. PubMed ID: 32514691 [TBL] [Abstract][Full Text] [Related]
28. Herpes zoster in eastern Saudi Arabia: clinical presentation and management. Alakloby OM; AlJabre SH; Randhawa MA; Alzahrani AJ; AlWunais KM; Bukhari IA J Drugs Dermatol; 2008 May; 7(5):457-62. PubMed ID: 18505138 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of varicella (VZV) vaccination: an update for the clinician. Wang L; Zhu L; Zhu H Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429 [TBL] [Abstract][Full Text] [Related]
31. Guillain-Barré syndrome following varicella-zoster virus infection: a case report and systematic review. Nerabani Y; Atli AA; Hamdan O; Hajjar Mwaffak A; Haj Hammadh NAH; Marstawi H; Hora S; Alabd N Ann Med Surg (Lond); 2023 Nov; 85(11):5621-5628. PubMed ID: 37915710 [TBL] [Abstract][Full Text] [Related]
32. Ramsay-Hunt syndrome: Report of two cases with identification of the varicella zoster virus genome in cerebrospinal fluid. Corti M; Villafañe MF; Correa J Biomedica; 2021 Dec; 41(4):625-630. PubMed ID: 34936248 [TBL] [Abstract][Full Text] [Related]
33. Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment. Jeon YH Korean J Pain; 2015 Jul; 28(3):177-84. PubMed ID: 26175877 [TBL] [Abstract][Full Text] [Related]
34. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. Kennedy PG; Rovnak J; Badani H; Cohrs RJ J Gen Virol; 2015 Jul; 96(Pt 7):1581-602. PubMed ID: 25794504 [TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular pathogenesis of varicella virus infection. Gilden DH; Cohrs RJ; Mahalingam R Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142 [TBL] [Abstract][Full Text] [Related]